Results 191 to 200 of about 62,873 (218)
Some of the next articles are maybe not open access.

T2 mapping as a marker of active myocardial injury in Anderson-Fabry disease patients

European Heart Journal
In Anderson-Fabry Disease (AFD) with cardiac involvement, left ventricular hypertrophy (LVH) is often associated with myocardial scarring by cardiovascular magnetic resonance (CMR) late gadolinium enhancement (LGE) imaging. Myocardial inflammation,
M. Schiavo   +13 more
semanticscholar   +1 more source

Anderson-Fabry's disease: Neuropathological and neurochemical investigation

Acta Neuropathologica, 1982
A clinical, neuropathological and neurochemical study of a case of Anderson-Fabry's disease is described. The clinical course mainly consisted of repeated ictus with major involvement of the CNS. The neuropathological examination is dominated by severe alterations in the cerebral vessels due to glycolipid deposits on the walls, with reduction or ...
Tagliavini, F.   +5 more
openaire   +3 more sources

Use of Myocardial T1 Mapping at 3.0 T to Differentiate Anderson-Fabry Disease from Hypertrophic Cardiomyopathy.

Radiology, 2018
Purpose To compare left ventricular (LV) and right ventricular (RV) 3.0-T cardiac magnetic resonance (MR) imaging T1 values in Anderson-Fabry disease (AFD) and hypertrophic cardiomyopathy (HCM) and evaluate the diagnostic value of native T1 values beyond
G. Karur   +9 more
semanticscholar   +1 more source

Prevalence of Anderson–Fabry disease in patients with hypertrophic cardiomyopathy: the European Anderson–Fabry Disease Survey

Heart, 2011
Objectives The prevalence of Anderson–Fabry disease (AFD) in patients presenting with unexplained left ventricular hypertrophy (LVH) is controversial. The aim of this study was to determine the prevalence of AFD in a large, consecutive cohort of patients with hypertrophic cardiomyopathy (HCM) using rapid mutation ...
Elliott P   +27 more
openaire   +5 more sources

Renal involvement in Anderson-Fabry disease.

Journal of nephrology, 2003
Anderson-Fabry disease (AFd) is a rare X-linked lisosomal storage disorder of glycosphingolipid (GL) metabolism, caused by a deficiency of the activity of alpha-galactosidase A (alpha-gal A). The progressive accumulation of GL in tissues results in the clinical manifestations of the disease, that are more evident in hemizygous males, and include ...
A. Sessa   +8 more
openaire   +2 more sources

NASCI case of the month: “pseudo normalization of T1 values in Anderson-Fabry disease”

The International Journal of Cardiovascular Imaging
Justin M Sarquiz, Elizabeth M Lee
semanticscholar   +1 more source

Anderson-Fabry Disease

2009
Hubert Scharnagl   +199 more
openaire   +1 more source

Achalasia in Anderson-Fabry's Disease

Journal of the Royal Society of Medicine, 1984
D H, Roberts, I T, Gilmore
openaire   +2 more sources

Anderson-Fabry disease. Conclusion

Giornale di Tecniche Nefrologiche e Dialitiche, 2017
Giovanni Duro, Marco Lombardi
openaire   +1 more source

Anderson-Fabry disease. Introduction

Giornale di Tecniche Nefrologiche e Dialitiche, 2017
Giovanni Duro, Marco Lombardi
openaire   +1 more source

Home - About - Disclaimer - Privacy